According to Latest Research by Market IntelliX, the global market for OTC and DTC Infectious Disease Diagnostic should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.

China OTC and DTC Infectious Disease Diagnostic market should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.

The United States OTC and DTC Infectious Disease Diagnostic market should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.

In terms of technology, PCR segment holds a share about % in 2023 and will reach % in 2030; while in terms of application, Diagnostic Laboratories has a share approximately % in 2023 and will grow at a CAGR % during 2023 and 2030.

The global key manufacturers of OTC and DTC Infectious Disease Diagnostic include Abbott, Bio-Rad Laboratories Inc, BD, Bosch Healthcare Solutions GmbH, Danaher, ThermoFisher Scientific, Siemens AG, Roche Holding AG and Hologic, Inc., etc. In 2023, the global top five players hold a share approximately % in terms of revenue.

In the manufacture and quality control of medicinal products, compliance with the GMP rules is the decisive aspect for manufacturing high-quality products. For this reason, every staff member in the pharmaceutical industry has to be familiar with the basic GMP requirements

This report aims to provide a comprehensive study of the global market for OTC and DTC Infectious Disease Diagnostic. Report Highlights:

(1) Global OTC and DTC Infectious Disease Diagnostic market size (value), history data from 2019-2024 and forecast data from 2024 to 2030.

(2) Global OTC and DTC Infectious Disease Diagnostic market competitive situation, revenue and market share, from 2019 to 2024.

(3) China OTC and DTC Infectious Disease Diagnostic market competitive situation, revenue and market share, from 2019 to 2024.

(4) Global OTC and DTC Infectious Disease Diagnostic segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.

(5) Global OTC and DTC Infectious Disease Diagnostic segment by type and by application and regional segment by type and by application.

(6) OTC and DTC Infectious Disease Diagnostic industry supply chain, upstream, midstream and downstream analysis.

Market segment by regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)

South America (Brazil, Rest of South America)

Middle East & Africa

Market segment by technology, covers

PCR

Immunodiagnostics

Clinical Microbiology

INAAT

DNA Sequencing and NGS

DNA Microarrays

Others

Market segment by application, can be divided into

Diagnostic Laboratories

Hospitals and Clinics

Academic Research Institutes

Others

Market segment by players, this report covers

Abbott

Bio-Rad Laboratories Inc

BD

Bosch Healthcare Solutions GmbH

Danaher

ThermoFisher Scientific

Siemens AG

Roche Holding AG

Hologic, Inc.

Qiagen

Cardinal Health

Quest Diagnostics Incorporated

Ador Diagnostics

Akonni Biosystems, Inc.

Alveo Technologies

Binx Health Inc.

bioMérieux, Inc.

Curetis

Sysmex Europe GmbH

Diasorin S.p.A

1 Market Overview

1.1 Product Overview and Scope of OTC and DTC Infectious Disease Diagnostic

1.2 Global OTC and DTC Infectious Disease Diagnostic Market Size and Forecast

1.3 China OTC and DTC Infectious Disease Diagnostic Market Size and Forecast

1.4 China Market Percentage in Global

1.4.1 By Revenue, China OTC and DTC Infectious Disease Diagnostic Share in Global Market, 2019-2030

1.4.2 OTC and DTC Infectious Disease Diagnostic Market Size: China VS Global, 2019-2030

1.5 OTC and DTC Infectious Disease Diagnostic Market Dynamics

1.5.1 OTC and DTC Infectious Disease Diagnostic Market Drivers

1.5.2 OTC and DTC Infectious Disease Diagnostic Market Restraints

1.5.3 OTC and DTC Infectious Disease Diagnostic Industry Trends

1.5.4 OTC and DTC Infectious Disease Diagnostic Industry Policy

2 Global Competitive Situation by Company

2.1 Global OTC and DTC Infectious Disease Diagnostic Revenue by Company (2019-2024)

2.2 Global OTC and DTC Infectious Disease Diagnostic Participants, Market Position (Tier 1, Tier 2 and Tier 3)

2.3 Global OTC and DTC Infectious Disease Diagnostic Concentration Ratio

2.4 Global OTC and DTC Infectious Disease Diagnostic Mergers & Acquisitions, Expansion Plans

2.5 Global OTC and DTC Infectious Disease Diagnostic Manufacturers Product Type

3 China Competitive Situation by Company

3.1 China OTC and DTC Infectious Disease Diagnostic Revenue by Company (2019-2024)

3.2 China OTC and DTC Infectious Disease Diagnostic OTC and DTC Infectious Disease Diagnostic Participants, Market Position (Tier 1, Tier 2 and Tier 3)

3.3 China OTC and DTC Infectious Disease Diagnostic, Revenue Percentage of Local Players VS Foreign Manufacturers (2019-2024)

4 Industry Chain Analysis

4.1 OTC and DTC Infectious Disease Diagnostic Industry Chain

4.2 OTC and DTC Infectious Disease Diagnostic Upstream Analysis

4.3 OTC and DTC Infectious Disease Diagnostic Midstream Analysis

4.4 OTC and DTC Infectious Disease Diagnostic Downstream Analysis

5 Sights by Technology

5.1 OTC and DTC Infectious Disease Diagnostic Classification

5.1.1 PCR

5.1.2 Immunodiagnostics

5.1.3 Clinical Microbiology

5.1.4 INAAT

5.1.5 DNA Sequencing and NGS

5.1.6 DNA Microarrays

5.1.7 Others

5.2 By Technology, Global OTC and DTC Infectious Disease Diagnostic Market Size & CAGR, 2019 VS 2024 VS 2030

5.3 By Technology, Global OTC and DTC Infectious Disease Diagnostic Revenue, 2019-2030

6 Sights by Application

6.1 OTC and DTC Infectious Disease Diagnostic Segment by Application

6.1.1 Diagnostic Laboratories

6.1.2 Hospitals and Clinics

6.1.3 Academic Research Institutes

6.1.4 Others

6.2 By Application, Global OTC and DTC Infectious Disease Diagnostic Market Size & CAGR, 2019 VS 2024 VS 2030

6.3 By Application, Global OTC and DTC Infectious Disease Diagnostic Revenue, 2019-2030

7 Sales Sights by Region

7.1 By Region, Global OTC and DTC Infectious Disease Diagnostic Market Size, 2019 VS 2024 VS 2030

7.2 By Region, Global OTC and DTC Infectious Disease Diagnostic Market Size, 2019-2030

7.3 North America

7.3.1 North America OTC and DTC Infectious Disease Diagnostic Market Size & Forecasts, 2019-2030

7.3.2 By Country, North America OTC and DTC Infectious Disease Diagnostic Market Size Market Share

7.4 Europe

7.4.1 Europe OTC and DTC Infectious Disease Diagnostic Market Size & Forecasts, 2019-2030

7.4.2 By Country, Europe OTC and DTC Infectious Disease Diagnostic Market Size Market Share

7.5 Asia Pacific

7.5.1 Asia Pacific OTC and DTC Infectious Disease Diagnostic Market Size & Forecasts, 2019-2030

7.5.2 By Country/Region, Asia Pacific OTC and DTC Infectious Disease Diagnostic Market Size Market Share

7.6 South America

7.6.1 South America OTC and DTC Infectious Disease Diagnostic Market Size & Forecasts, 2019-2030

7.6.2 By Country, South America OTC and DTC Infectious Disease Diagnostic Market Size Market Share

7.7 Middle East & Africa

8 Sights by Country Level

8.1 By Country, Global OTC and DTC Infectious Disease Diagnostic Market Size & CAGR，2019 VS 2024 VS 2030

8.2 By Country, Global OTC and DTC Infectious Disease Diagnostic Market Size, 2019-2030

8.3 U.S.

8.3.1 U.S. OTC and DTC Infectious Disease Diagnostic Market Size, 2019-2030

8.3.2 By Company, U.S. OTC and DTC Infectious Disease Diagnostic Revenue Market Share, 2019-2024

8.3.3 By Technology, U.S. OTC and DTC Infectious Disease Diagnostic Revenue Market Share, 2024 VS 2030

8.3.4 By Application, U.S. OTC and DTC Infectious Disease Diagnostic Revenue Market Share, 2024 VS 2030

8.4 Europe

8.4.1 Europe OTC and DTC Infectious Disease Diagnostic Market Size, 2019-2030

8.4.2 By Company, Europe OTC and DTC Infectious Disease Diagnostic Revenue Market Share, 2019-2024

8.4.3 By Technology, Europe OTC and DTC Infectious Disease Diagnostic Revenue Market Share, 2024 VS 2030

8.4.4 By Application, Europe OTC and DTC Infectious Disease Diagnostic Revenue Market Share, 2024 VS 2030

8.5 China

8.5.1 China OTC and DTC Infectious Disease Diagnostic Market Size, 2019-2030

8.5.2 By Company, China OTC and DTC Infectious Disease Diagnostic Revenue Market Share, 2019-2024

8.5.3 By Technology, China OTC and DTC Infectious Disease Diagnostic Revenue Market Share, 2024 VS 2030

8.5.4 By Application, China OTC and DTC Infectious Disease Diagnostic Revenue Market Share, 2024 VS 2030

8.6 Japan

8.6.1 Japan OTC and DTC Infectious Disease Diagnostic Market Size, 2019-2030

8.6.2 By Company, Japan OTC and DTC Infectious Disease Diagnostic Revenue Market Share, 2019-2024

8.6.3 By Technology, Japan OTC and DTC Infectious Disease Diagnostic Revenue Market Share, 2024 VS 2030

8.6.4 By Application, Japan OTC and DTC Infectious Disease Diagnostic Revenue Market Share, 2024 VS 2030

8.7 South Korea

8.7.1 South Korea OTC and DTC Infectious Disease Diagnostic Market Size, 2019-2030

8.7.2 By Company, South Korea OTC and DTC Infectious Disease Diagnostic Revenue Market Share, 2019-2024

8.7.3 By Technology, South Korea OTC and DTC Infectious Disease Diagnostic Revenue Market Share, 2024 VS 2030

8.7.4 By Application, South Korea OTC and DTC Infectious Disease Diagnostic Revenue Market Share, 2024 VS 2030

8.8 Southeast Asia

8.8.1 Southeast Asia OTC and DTC Infectious Disease Diagnostic Market Size, 2019-2030

8.8.2 By Company, Southeast Asia OTC and DTC Infectious Disease Diagnostic Revenue Market Share, 2019-2024

8.8.3 By Technology, Southeast Asia OTC and DTC Infectious Disease Diagnostic Revenue Market Share, 2024 VS 2030

8.8.4 By Application, Southeast Asia OTC and DTC Infectious Disease Diagnostic Revenue Market Share, 2024 VS 2030

8.9 India

8.9.1 India OTC and DTC Infectious Disease Diagnostic Market Size, 2019-2030

8.9.2 By Company, India OTC and DTC Infectious Disease Diagnostic Revenue Market Share, 2019-2024

8.9.3 By Technology, India OTC and DTC Infectious Disease Diagnostic Revenue Market Share, 2024 VS 2030

8.9.4 By Application, India OTC and DTC Infectious Disease Diagnostic Revenue Market Share, 2024 VS 2030

8.10 Middle East & Asia

8.10.1 Middle East & Asia OTC and DTC Infectious Disease Diagnostic Market Size, 2019-2030

8.10.2 By Company, Middle East & Asia OTC and DTC Infectious Disease Diagnostic Revenue Market Share, 2019-2024

8.10.3 By Technology, Middle East & Asia OTC and DTC Infectious Disease Diagnostic Revenue Market Share, 2024 VS 2030

8.10.4 By Application, Middle East & Asia OTC and DTC Infectious Disease Diagnostic Revenue Market Share, 2024 VS 2030

9 Global Manufacturers Profile

9.1 Abbott

9.1.1 Abbott Company Information, Head Office, Market Area and Industry Position

9.1.2 Abbott Company Profile and Main Business

9.1.3 Abbott OTC and DTC Infectious Disease Diagnostic Models, Specifications and Application

9.1.4 Abbott OTC and DTC Infectious Disease Diagnostic Revenue and Gross Margin, 2019-2024

9.1.5 Abbott Recent Developments

9.2 Bio-Rad Laboratories Inc

9.2.1 Bio-Rad Laboratories Inc Company Information, Head Office, Market Area and Industry Position

9.2.2 Bio-Rad Laboratories Inc Company Profile and Main Business

9.2.3 Bio-Rad Laboratories Inc OTC and DTC Infectious Disease Diagnostic Models, Specifications and Application

9.2.4 Bio-Rad Laboratories Inc OTC and DTC Infectious Disease Diagnostic Revenue and Gross Margin, 2019-2024

9.2.5 Bio-Rad Laboratories Inc Recent Developments

9.3 BD

9.3.1 BD Company Information, Head Office, Market Area and Industry Position

9.3.2 BD Company Profile and Main Business

9.3.3 BD OTC and DTC Infectious Disease Diagnostic Models, Specifications and Application

9.3.4 BD OTC and DTC Infectious Disease Diagnostic Revenue and Gross Margin, 2019-2024

9.3.5 BD Recent Developments

9.4 Bosch Healthcare Solutions GmbH

9.4.1 Bosch Healthcare Solutions GmbH Company Information, Head Office, Market Area and Industry Position

9.4.2 Bosch Healthcare Solutions GmbH Company Profile and Main Business

9.4.3 Bosch Healthcare Solutions GmbH OTC and DTC Infectious Disease Diagnostic Models, Specifications and Application

9.4.4 Bosch Healthcare Solutions GmbH OTC and DTC Infectious Disease Diagnostic Revenue and Gross Margin, 2019-2024

9.4.5 Bosch Healthcare Solutions GmbH Recent Developments

9.5 Danaher

9.5.1 Danaher Company Information, Head Office, Market Area and Industry Position

9.5.2 Danaher Company Profile and Main Business

9.5.3 Danaher OTC and DTC Infectious Disease Diagnostic Models, Specifications and Application

9.5.4 Danaher OTC and DTC Infectious Disease Diagnostic Revenue and Gross Margin, 2019-2024

9.5.5 Danaher Recent Developments

9.6 ThermoFisher Scientific

9.6.1 ThermoFisher Scientific Company Information, Head Office, Market Area and Industry Position

9.6.2 ThermoFisher Scientific Company Profile and Main Business

9.6.3 ThermoFisher Scientific OTC and DTC Infectious Disease Diagnostic Models, Specifications and Application

9.6.4 ThermoFisher Scientific OTC and DTC Infectious Disease Diagnostic Revenue and Gross Margin, 2019-2024

9.6.5 ThermoFisher Scientific Recent Developments

9.7 Siemens AG

9.7.1 Siemens AG Company Information, Head Office, Market Area and Industry Position

9.7.2 Siemens AG Company Profile and Main Business

9.7.3 Siemens AG OTC and DTC Infectious Disease Diagnostic Models, Specifications and Application

9.7.4 Siemens AG OTC and DTC Infectious Disease Diagnostic Revenue and Gross Margin, 2019-2024

9.7.5 Siemens AG Recent Developments

9.8 Roche Holding AG

9.8.1 Roche Holding AG Company Information, Head Office, Market Area and Industry Position

9.8.2 Roche Holding AG Company Profile and Main Business

9.8.3 Roche Holding AG OTC and DTC Infectious Disease Diagnostic Models, Specifications and Application

9.8.4 Roche Holding AG OTC and DTC Infectious Disease Diagnostic Revenue and Gross Margin, 2019-2024

9.8.5 Roche Holding AG Recent Developments

9.9 Hologic, Inc.

9.9.1 Hologic, Inc. Company Information, Head Office, Market Area and Industry Position

9.9.2 Hologic, Inc. Company Profile and Main Business

9.9.3 Hologic, Inc. OTC and DTC Infectious Disease Diagnostic Models, Specifications and Application

9.9.4 Hologic, Inc. OTC and DTC Infectious Disease Diagnostic Revenue and Gross Margin, 2019-2024

9.9.5 Hologic, Inc. Recent Developments

9.10 Qiagen

9.10.1 Qiagen Company Information, Head Office, Market Area and Industry Position

9.10.2 Qiagen Company Profile and Main Business

9.10.3 Qiagen OTC and DTC Infectious Disease Diagnostic Models, Specifications and Application

9.10.4 Qiagen OTC and DTC Infectious Disease Diagnostic Revenue and Gross Margin, 2019-2024

9.10.5 Qiagen Recent Developments

9.11 Cardinal Health

9.11.1 Cardinal Health Company Information, Head Office, Market Area and Industry Position

9.11.2 Cardinal Health Company Profile and Main Business

9.11.3 Cardinal Health OTC and DTC Infectious Disease Diagnostic Models, Specifications and Application

9.11.4 Cardinal Health OTC and DTC Infectious Disease Diagnostic Revenue and Gross Margin, 2019-2024

9.11.5 Cardinal Health Recent Developments

9.12 Quest Diagnostics Incorporated

9.12.1 Quest Diagnostics Incorporated Company Information, Head Office, Market Area and Industry Position

9.12.2 Quest Diagnostics Incorporated Company Profile and Main Business

9.12.3 Quest Diagnostics Incorporated OTC and DTC Infectious Disease Diagnostic Models, Specifications and Application

9.12.4 Quest Diagnostics Incorporated OTC and DTC Infectious Disease Diagnostic Revenue and Gross Margin, 2019-2024

9.12.5 Quest Diagnostics Incorporated Recent Developments

9.13 Ador Diagnostics

9.13.1 Ador Diagnostics Company Information, Head Office, Market Area and Industry Position

9.13.2 Ador Diagnostics Company Profile and Main Business

9.13.3 Ador Diagnostics OTC and DTC Infectious Disease Diagnostic Models, Specifications and Application

9.13.4 Ador Diagnostics OTC and DTC Infectious Disease Diagnostic Revenue and Gross Margin, 2019-2024

9.13.5 Ador Diagnostics Recent Developments

9.14 Akonni Biosystems, Inc.

9.14.1 Akonni Biosystems, Inc. Company Information, Head Office, Market Area and Industry Position

9.14.2 Akonni Biosystems, Inc. Company Profile and Main Business

9.14.3 Akonni Biosystems, Inc. OTC and DTC Infectious Disease Diagnostic Models, Specifications and Application

9.14.4 Akonni Biosystems, Inc. OTC and DTC Infectious Disease Diagnostic Revenue and Gross Margin, 2019-2024

9.14.5 Akonni Biosystems, Inc. Recent Developments

9.15 Alveo Technologies

9.15.1 Alveo Technologies Company Information, Head Office, Market Area and Industry Position

9.15.2 Alveo Technologies Company Profile and Main Business

9.15.3 Alveo Technologies OTC and DTC Infectious Disease Diagnostic Models, Specifications and Application

9.15.4 Alveo Technologies OTC and DTC Infectious Disease Diagnostic Revenue and Gross Margin, 2019-2024

9.15.5 Alveo Technologies Recent Developments

9.16 Binx Health Inc.

9.16.1 Binx Health Inc. Company Information, Head Office, Market Area and Industry Position

9.16.2 Binx Health Inc. Company Profile and Main Business

9.16.3 Binx Health Inc. OTC and DTC Infectious Disease Diagnostic Models, Specifications and Application

9.16.4 Binx Health Inc. OTC and DTC Infectious Disease Diagnostic Revenue and Gross Margin, 2019-2024

9.16.5 Binx Health Inc. Recent Developments

9.17 bioMérieux, Inc.

9.17.1 bioMérieux, Inc. Company Information, Head Office, Market Area and Industry Position

9.17.2 bioMérieux, Inc. Company Profile and Main Business

9.17.3 bioMérieux, Inc. OTC and DTC Infectious Disease Diagnostic Models, Specifications and Application

9.17.4 bioMérieux, Inc. OTC and DTC Infectious Disease Diagnostic Revenue and Gross Margin, 2019-2024

9.17.5 bioMérieux, Inc. Recent Developments

9.18 Curetis

9.18.1 Curetis Company Information, Head Office, Market Area and Industry Position

9.18.2 Curetis Company Profile and Main Business

9.18.3 Curetis OTC and DTC Infectious Disease Diagnostic Models, Specifications and Application

9.18.4 Curetis OTC and DTC Infectious Disease Diagnostic Revenue and Gross Margin, 2019-2024

9.18.5 Curetis Recent Developments

9.19 Sysmex Europe GmbH

9.19.1 Sysmex Europe GmbH Company Information, Head Office, Market Area and Industry Position

9.19.2 Sysmex Europe GmbH Company Profile and Main Business

9.19.3 Sysmex Europe GmbH OTC and DTC Infectious Disease Diagnostic Models, Specifications and Application

9.19.4 Sysmex Europe GmbH OTC and DTC Infectious Disease Diagnostic Revenue and Gross Margin, 2019-2024

9.19.5 Sysmex Europe GmbH Recent Developments

9.20 Diasorin S.p.A

9.20.1 Diasorin S.p.A Company Information, Head Office, Market Area and Industry Position

9.20.2 Diasorin S.p.A Company Profile and Main Business

9.20.3 Diasorin S.p.A OTC and DTC Infectious Disease Diagnostic Models, Specifications and Application

9.20.4 Diasorin S.p.A OTC and DTC Infectious Disease Diagnostic Revenue and Gross Margin, 2019-2024

9.20.5 Diasorin S.p.A Recent Developments

10 Conclusion

11 Appendix

11.1 Research Methodology

11.2 Data Source

11.2.1 Secondary Sources

11.2.2 Primary Sources

11.3 Market Estimation Model

11.4 Disclaimer

Table 1. OTC and DTC Infectious Disease Diagnostic Market Size & CAGR: China VS Global, (US$ Million), 2019-2030

Table 2. OTC and DTC Infectious Disease Diagnostic Market Restraints

Table 3. OTC and DTC Infectious Disease Diagnostic Market Trends

Table 4. OTC and DTC Infectious Disease Diagnostic Industry Policy

Table 5. Global OTC and DTC Infectious Disease Diagnostic Revenue by Company (2019-2024) & (US$ million)

Table 6. Global OTC and DTC Infectious Disease Diagnostic Revenue Market Share by Company (2019-2024)

Table 7. Global OTC and DTC Infectious Disease Diagnostic Manufacturers Market Concentration Ratio (CR3 and HHI)

Table 8. Global OTC and DTC Infectious Disease Diagnostic Mergers & Acquisitions, Expansion Plans

Table 9. Global OTC and DTC Infectious Disease Diagnostic Manufacturers Product Type

Table 10. China OTC and DTC Infectious Disease Diagnostic Revenue by Company (2019-2024) & (US$ million)

Table 11. China OTC and DTC Infectious Disease Diagnostic Revenue Market Share by Company (2019-2024)

Table 12. Global Key Players of OTC and DTC Infectious Disease Diagnostic Upstream (Raw Materials)

Table 13. Global OTC and DTC Infectious Disease Diagnostic Typical Customers

Table 14. OTC and DTC Infectious Disease Diagnostic Typical Distributors

Table 15. By Technology, Global OTC and DTC Infectious Disease Diagnostic Revenue & CAGR, 2019 VS 2024 VS 2030, US$ Million

Table 16. By Application, Global OTC and DTC Infectious Disease Diagnostic Revenue & CAGR, 2019 VS 2024 VS 2030, US$ Million

Table 17. By Region, Global OTC and DTC Infectious Disease Diagnostic Market Size, 2019 VS 2024 VS 2030, US$ Million

Table 18. By Region, Global OTC and DTC Infectious Disease Diagnostic Revenue, 2019-2030, US$ Million

Table 19. By Country, Global OTC and DTC Infectious Disease Diagnostic Revenue & CAGR，2019 VS 2024 VS 2030, US$ Million

Table 20. By Country, Global OTC and DTC Infectious Disease Diagnostic Revenue, 2019-2030, US$ Million

Table 21. By Country, Global OTC and DTC Infectious Disease Diagnostic Revenue Market Share, 2019-2030

Table 22. Abbott Company Information, Head Office, Market Area and Industry Position

Table 23. Abbott Company Profile and Main Business

Table 24. Abbott OTC and DTC Infectious Disease Diagnostic Models, Specifications and Application

Table 25. Abbott OTC and DTC Infectious Disease Diagnostic Revenue and Gross Margin, 2019-2024

Table 26. Abbott Recent Developments

Table 27. Bio-Rad Laboratories Inc Company Information, Head Office, Market Area and Industry Position

Table 28. Bio-Rad Laboratories Inc Company Profile and Main Business

Table 29. Bio-Rad Laboratories Inc OTC and DTC Infectious Disease Diagnostic Models, Specifications and Application

Table 30. Bio-Rad Laboratories Inc OTC and DTC Infectious Disease Diagnostic Revenue and Gross Margin, 2019-2024

Table 31. Bio-Rad Laboratories Inc Recent Developments

Table 32. BD Company Information, Head Office, Market Area and Industry Position

Table 33. BD Company Profile and Main Business

Table 34. BD OTC and DTC Infectious Disease Diagnostic Models, Specifications and Application

Table 35. BD OTC and DTC Infectious Disease Diagnostic Revenue and Gross Margin, 2019-2024

Table 36. BD Recent Developments

Table 37. Bosch Healthcare Solutions GmbH Company Information, Head Office, Market Area and Industry Position

Table 38. Bosch Healthcare Solutions GmbH Company Profile and Main Business

Table 39. Bosch Healthcare Solutions GmbH OTC and DTC Infectious Disease Diagnostic Models, Specifications and Application

Table 40. Bosch Healthcare Solutions GmbH OTC and DTC Infectious Disease Diagnostic Revenue and Gross Margin, 2019-2024

Table 41. Bosch Healthcare Solutions GmbH Recent Developments

Table 42. Danaher Company Information, Head Office, Market Area and Industry Position

Table 43. Danaher Company Profile and Main Business

Table 44. Danaher OTC and DTC Infectious Disease Diagnostic Models, Specifications and Application

Table 45. Danaher OTC and DTC Infectious Disease Diagnostic Revenue and Gross Margin, 2019-2024

Table 46. Danaher Recent Developments

Table 47. ThermoFisher Scientific Company Information, Head Office, Market Area and Industry Position

Table 48. ThermoFisher Scientific Company Profile and Main Business

Table 49. ThermoFisher Scientific OTC and DTC Infectious Disease Diagnostic Models, Specifications and Application

Table 50. ThermoFisher Scientific OTC and DTC Infectious Disease Diagnostic Revenue and Gross Margin, 2019-2024

Table 51. ThermoFisher Scientific Recent Developments

Table 52. Siemens AG Company Information, Head Office, Market Area and Industry Position

Table 53. Siemens AG Company Profile and Main Business

Table 54. Siemens AG OTC and DTC Infectious Disease Diagnostic Models, Specifications and Application

Table 55. Siemens AG OTC and DTC Infectious Disease Diagnostic Revenue and Gross Margin, 2019-2024

Table 56. Siemens AG Recent Developments

Table 57. Roche Holding AG Company Information, Head Office, Market Area and Industry Position

Table 58. Roche Holding AG Company Profile and Main Business

Table 59. Roche Holding AG OTC and DTC Infectious Disease Diagnostic Models, Specifications and Application

Table 60. Roche Holding AG OTC and DTC Infectious Disease Diagnostic Revenue and Gross Margin, 2019-2024

Table 61. Roche Holding AG Recent Developments

Table 62. Hologic, Inc. Company Information, Head Office, Market Area and Industry Position

Table 63. Hologic, Inc. Company Profile and Main Business

Table 64. Hologic, Inc. OTC and DTC Infectious Disease Diagnostic Models, Specifications and Application

Table 65. Hologic, Inc. OTC and DTC Infectious Disease Diagnostic Revenue and Gross Margin, 2019-2024

Table 66. Hologic, Inc. Recent Developments

Table 67. Qiagen Company Information, Head Office, Market Area and Industry Position

Table 68. Qiagen Company Profile and Main Business

Table 69. Qiagen OTC and DTC Infectious Disease Diagnostic Models, Specifications and Application

Table 70. Qiagen OTC and DTC Infectious Disease Diagnostic Revenue and Gross Margin, 2019-2024

Table 71. Qiagen Recent Developments

Table 72. Cardinal Health Company Information, Head Office, Market Area and Industry Position

Table 73. Cardinal Health Company Profile and Main Business

Table 74. Cardinal Health OTC and DTC Infectious Disease Diagnostic Models, Specifications and Application

Table 75. Cardinal Health OTC and DTC Infectious Disease Diagnostic Revenue and Gross Margin, 2019-2024

Table 76. Cardinal Health Recent Developments

Table 77. Quest Diagnostics Incorporated Company Information, Head Office, Market Area and Industry Position

Table 78. Quest Diagnostics Incorporated Company Profile and Main Business

Table 79. Quest Diagnostics Incorporated OTC and DTC Infectious Disease Diagnostic Models, Specifications and Application

Table 80. Quest Diagnostics Incorporated OTC and DTC Infectious Disease Diagnostic Revenue and Gross Margin, 2019-2024

Table 81. Quest Diagnostics Incorporated Recent Developments

Table 82. Ador Diagnostics Company Information, Head Office, Market Area and Industry Position

Table 83. Ador Diagnostics Company Profile and Main Business

Table 84. Ador Diagnostics OTC and DTC Infectious Disease Diagnostic Models, Specifications and Application

Table 85. Ador Diagnostics OTC and DTC Infectious Disease Diagnostic Revenue and Gross Margin, 2019-2024

Table 86. Ador Diagnostics Recent Developments

Table 87. Akonni Biosystems, Inc. Company Information, Head Office, Market Area and Industry Position

Table 88. Akonni Biosystems, Inc. Company Profile and Main Business

Table 89. Akonni Biosystems, Inc. OTC and DTC Infectious Disease Diagnostic Models, Specifications and Application

Table 90. Akonni Biosystems, Inc. OTC and DTC Infectious Disease Diagnostic Revenue and Gross Margin, 2019-2024

Table 91. Akonni Biosystems, Inc. Recent Developments

Table 92. Alveo Technologies Company Information, Head Office, Market Area and Industry Position

Table 93. Alveo Technologies Company Profile and Main Business

Table 94. Alveo Technologies OTC and DTC Infectious Disease Diagnostic Models, Specifications and Application

Table 95. Alveo Technologies OTC and DTC Infectious Disease Diagnostic Revenue and Gross Margin, 2019-2024

Table 96. Alveo Technologies Recent Developments

Table 97. Binx Health Inc. Company Information, Head Office, Market Area and Industry Position

Table 98. Binx Health Inc. Company Profile and Main Business

Table 99. Binx Health Inc. OTC and DTC Infectious Disease Diagnostic Models, Specifications and Application

Table 100. Binx Health Inc. OTC and DTC Infectious Disease Diagnostic Revenue and Gross Margin, 2019-2024

Table 101. Binx Health Inc. Recent Developments

Table 102. bioMérieux, Inc. Company Information, Head Office, Market Area and Industry Position

Table 103. bioMérieux, Inc. Company Profile and Main Business

Table 104. bioMérieux, Inc. OTC and DTC Infectious Disease Diagnostic Models, Specifications and Application

Table 105. bioMérieux, Inc. OTC and DTC Infectious Disease Diagnostic Revenue and Gross Margin, 2019-2024

Table 106. bioMérieux, Inc. Recent Developments

Table 107. Curetis Company Information, Head Office, Market Area and Industry Position

Table 108. Curetis Company Profile and Main Business

Table 109. Curetis OTC and DTC Infectious Disease Diagnostic Models, Specifications and Application

Table 110. Curetis OTC and DTC Infectious Disease Diagnostic Revenue and Gross Margin, 2019-2024

Table 111. Curetis Recent Developments

Table 112. Sysmex Europe GmbH Company Information, Head Office, Market Area and Industry Position

Table 113. Sysmex Europe GmbH Company Profile and Main Business

Table 114. Sysmex Europe GmbH OTC and DTC Infectious Disease Diagnostic Models, Specifications and Application

Table 115. Sysmex Europe GmbH OTC and DTC Infectious Disease Diagnostic Revenue and Gross Margin, 2019-2024

Table 116. Sysmex Europe GmbH Recent Developments

Table 117. Diasorin S.p.A Company Information, Head Office, Market Area and Industry Position

Table 118. Diasorin S.p.A Company Profile and Main Business

Table 119. Diasorin S.p.A OTC and DTC Infectious Disease Diagnostic Models, Specifications and Application

Table 120. Diasorin S.p.A OTC and DTC Infectious Disease Diagnostic Revenue and Gross Margin, 2019-2024

Table 121. Diasorin S.p.A Recent Developments

List of Figure

Figure 1. OTC and DTC Infectious Disease Diagnostic Picture

Figure 2. Global OTC and DTC Infectious Disease Diagnostic Industry Market Size and Forecast (US$ million) & (2019-2030)

Figure 3. China OTC and DTC Infectious Disease Diagnostic Revenue and Forecast (US$ million) & (2019-2030)

Figure 4. 2019-2030 China OTC and DTC Infectious Disease Diagnostic Market Share of Global

Figure 5. Global OTC and DTC Infectious Disease Diagnostic Key Participants, Market Share, 2021 VS 2023 VS 2023

Figure 6. Global OTC and DTC Infectious Disease Diagnostic Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2019-2024

Figure 7. China OTC and DTC Infectious Disease Diagnostic Key Participants, Market Share, 2021 VS 2023 VS 2023

Figure 8. China OTC and DTC Infectious Disease Diagnostic Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2019-2024

Figure 9. OTC and DTC Infectious Disease Diagnostic Industry Chain

Figure 10. PCR

Figure 11. Immunodiagnostics

Figure 12. Clinical Microbiology

Figure 13. INAAT

Figure 14. DNA Sequencing and NGS

Figure 15. DNA Microarrays

Figure 16. Others

Figure 17. By Technology, Global OTC and DTC Infectious Disease Diagnostic Revenue, 2019-2030, US$ Million

Figure 18. By Technology, Global OTC and DTC Infectious Disease Diagnostic Revenue Market Share, 2019-2030

Figure 19. Diagnostic Laboratories

Figure 20. Hospitals and Clinics

Figure 21. Academic Research Institutes

Figure 22. Others

Figure 23. By Application, Global OTC and DTC Infectious Disease Diagnostic Revenue, 2019-2030, US$ Million

Figure 24. By Application, Global OTC and DTC Infectious Disease Diagnostic Revenue Market Share, 2019-2030

Figure 25. By Region, Global OTC and DTC Infectious Disease Diagnostic Revenue Market Share, 2019-2030

Figure 26. North America OTC and DTC Infectious Disease Diagnostic Revenue & Forecasts, 2019-2030, US$ Million

Figure 27. By Country, North America OTC and DTC Infectious Disease Diagnostic Revenue Market Share, 2019-2024

Figure 28. Europe OTC and DTC Infectious Disease Diagnostic Revenue & Forecasts, 2019-2030, US$ Million

Figure 29. By Country, Europe OTC and DTC Infectious Disease Diagnostic Revenue Market Share, 2019-2024

Figure 30. Asia Pacific OTC and DTC Infectious Disease Diagnostic Revenue & Forecasts, 2019-2030, US$ Million

Figure 31. By Country/Region, Asia Pacific OTC and DTC Infectious Disease Diagnostic Revenue Market Share, 2019-2024

Figure 32. South America OTC and DTC Infectious Disease Diagnostic Revenue & Forecasts, 2019-2030, US$ Million

Figure 33. By Country, South America OTC and DTC Infectious Disease Diagnostic Revenue Market Share, 2019-2024

Figure 34. Middle East & Africa OTC and DTC Infectious Disease Diagnostic Revenue & Forecasts, 2019-2030, US$ Million

Figure 35. U.S. OTC and DTC Infectious Disease Diagnostic Revenue, 2019-2030, (US$ Million)

Figure 36. By Company, U.S. OTC and DTC Infectious Disease Diagnostic Market Share, 2019-2024

Figure 37. By Technology, U.S. OTC and DTC Infectious Disease Diagnostic Revenue Market Share, 2023 VS 2030

Figure 38. By Application, U.S. OTC and DTC Infectious Disease Diagnostic Revenue Market Share, 2023 VS 2030

Figure 39. Europe OTC and DTC Infectious Disease Diagnostic Revenue, 2019-2030, (US$ Million)

Figure 40. By Company, Europe OTC and DTC Infectious Disease Diagnostic Market Share, 2019-2024

Figure 41. By Technology, Europe OTC and DTC Infectious Disease Diagnostic Revenue Market Share, 2023 VS 2030

Figure 42. By Application, Europe OTC and DTC Infectious Disease Diagnostic Revenue Market Share, 2023 VS 2030

Figure 43. China OTC and DTC Infectious Disease Diagnostic Revenue, 2019-2030, (US$ Million)

Figure 44. By Company, China OTC and DTC Infectious Disease Diagnostic Market Share, 2019-2024

Figure 45. By Technology, China OTC and DTC Infectious Disease Diagnostic Revenue Market Share, 2023 VS 2030

Figure 46. By Application, China OTC and DTC Infectious Disease Diagnostic Revenue Market Share, 2023 VS 2030

Figure 47. Japan OTC and DTC Infectious Disease Diagnostic Revenue, 2019-2030, (US$ Million)

Figure 48. By Company, Japan OTC and DTC Infectious Disease Diagnostic Market Share, 2019-2024

Figure 49. By Technology, Japan OTC and DTC Infectious Disease Diagnostic Revenue Market Share, 2023 VS 2030

Figure 50. By Application, Japan OTC and DTC Infectious Disease Diagnostic Revenue Market Share, 2023 VS 2030

Figure 51. South Korea OTC and DTC Infectious Disease Diagnostic Revenue, 2019-2030, (US$ Million)

Figure 52. By Company, South Korea OTC and DTC Infectious Disease Diagnostic Market Share, 2019-2024

Figure 53. By Technology, South Korea OTC and DTC Infectious Disease Diagnostic Revenue Market Share, 2023 VS 2030

Figure 54. By Application, South Korea OTC and DTC Infectious Disease Diagnostic Revenue Market Share, 2023 VS 2030

Figure 55. Southeast Asia OTC and DTC Infectious Disease Diagnostic Revenue, 2019-2030, (US$ Million)

Figure 56. By Company, Southeast Asia OTC and DTC Infectious Disease Diagnostic Market Share, 2019-2024

Figure 57. By Technology, Southeast Asia OTC and DTC Infectious Disease Diagnostic Revenue Market Share, 2023 VS 2030

Figure 58. By Application, Southeast Asia OTC and DTC Infectious Disease Diagnostic Revenue Market Share, 2023 VS 2030

Figure 59. India OTC and DTC Infectious Disease Diagnostic Revenue, 2019-2030, (US$ Million)

Figure 60. By Company, India OTC and DTC Infectious Disease Diagnostic Market Share, 2019-2024

Figure 61. By Technology, India OTC and DTC Infectious Disease Diagnostic Revenue Market Share, 2023 VS 2030

Figure 62. By Application, India OTC and DTC Infectious Disease Diagnostic Revenue Market Share, 2023 VS 2030

Figure 63. Middle East & Asia OTC and DTC Infectious Disease Diagnostic Revenue, 2019-2030, (US$ Million)

Figure 64. By Company, Middle East & Asia OTC and DTC Infectious Disease Diagnostic Market Share, 2019-2024

Figure 65. By Technology, Middle East & Asia OTC and DTC Infectious Disease Diagnostic Revenue Market Share, 2023 VS 2030

Figure 66. By Application, Middle East & Asia OTC and DTC Infectious Disease Diagnostic Revenue Market Share, 2023 VS 2030

Figure 67. Research Methodology

Figure 68. Breakdown of Primary Interviews

Figure 69. Bottom-up Approaches

Figure 70. Top-down Approaches

Methodology/Research Approach

This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.

Research Programs/Design

Historical Data (2015-2019)	Industry Trends Competitive Landscape By Company Expansion Mergers and Acquisitions Market Segment by Type by Application By Regions/ Geography	Value Status and Outlook Value for Major Players Market Share Growth Rate Present Situation Analysis Value Market Share Growth Rate Present Situation Analysis
Influencing Factors	Market Environment Government Policy Technological Changes Market Risks	Market Drivers Growing Demand of Downstream Reduction in Cost
Market Forecast (2021-2026)	Overall Size by Type by Application By Regions/Geography	Key Data (Value) Market Share Growth Rate CAGR (2021-2026)

Market Size Estimation

Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).

The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.

Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.

All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report

The following figure shows an illustrative representation of the overall market size estimation process used for this study.

Market Breakdown and Data Triangulation

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.

Data Source

Secondary Sources

Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.

Market Size	Segmental value Geographic Penetration Product Adoption Rate for Different market	Journals, Websites, and Press Releases Annual Reports and SEC Filings Company Websites and Press Releases Public and Paid Databases Market Intellix Data Repository
Market Position of Top Company	Product Financials Geographic value Mix Total Company value Business/Segmental value Mix
Qualitative Analysis	Influence Factors Market Potential Market Risks and Opportunities Industry Trends Geographical Features Government Policies	Company Websites and Press Releases Public and Paid Databases Annual Reports Industry Associations Market Intellix Data Repository

Primary Sources

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.

Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.

Key Executives Interviewed

Key Data Information from Primary Sources

Primary Sources	Parameters	Key Data
Market Segments(by Application, by Type)	Value by Type Status and Forecast Value by Application Value by Regions, Status and Forecast (2021-2026)	Value Market Share by Type Value Growth Rate by Type Value by Application Percentage and Growth Rate by Application Value Growth Rate and Market Share by Regions Market Size Status and Forecast (2021-2026)
Total Market	Overall Size, Status and Forecast	Market Size Status and Forecast (2021-2026)